Jeffrey J. Scherman - 02 Oct 2025 Form 4 Insider Report for NeueHealth, Inc. (NEUE)

Reporting relationship: Chief Accounting Officer
Issuer ticker: NEUE
Reported as of: 02 Oct 2025
Net transaction value: -$91,354
SEC form: 4
Accepted by SEC: 06 Oct 2025, 18:23:20 UTC
Prior SEC filing: 14 May 2025
Source filing: View source filing
Reporting owner signature: /s/ Eric Halverson for Jeffrey J. Scherman, Attorney-in-Fact

Key filing fact

Jeffrey J. Scherman filed Form 4 for NeueHealth, Inc. (NEUE) on 06 Oct 2025.

Key facts

This page summarizes Jeffrey J. Scherman's Form 4 filing for NeueHealth, Inc. (NEUE).
4 reported transactions and 3 derivative rows are listed below.
Accepted by SEC: 06 Oct 2025, 18:23.

Change

Previous filing in this sequence was filed on 14 May 2025.
Current net transaction value: -$91,354.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001867147 Primary reporting owner

Scherman Jeffrey J

Relationship: Chief Accounting Officer
Address: C/O NEUEHEALTH, INC., 9250 NW 36TH ST SUITE 420, DORAL
Signature: /s/ Eric Halverson for Jeffrey J. Scherman, Attorney-in-Fact
Signature date: 06 Oct 2025

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

NEUE transaction

Common Stock

Disposed to Issuer

Transaction value: $91,354
Shares: -12,463
Change %: -100%
Price: $7.33
Shares after: 0
Date: 02 Oct 2025
Ownership: Direct
Footnotes: F1, F2

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

NEUE transaction Derivative

Restricted Stock Units

Disposed to Issuer

Transaction value
Shares: -11,000
Change %: -100%
Price
Shares after: 0
Date: 02 Oct 2025
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 11,000
Exercise price
Footnotes: F1, F3, F4, F5

NEUE transaction Derivative

Restricted Stock Units

Disposed to Issuer

Transaction value
Shares: -50,000
Change %: -100%
Price
Shares after: 0
Date: 02 Oct 2025
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 50,000
Exercise price
Footnotes: F1, F3, F5, F6

NEUE transaction Derivative

Restricted Stock Units

Disposed to Issuer

Transaction value
Shares: -2,490
Change %: -100%
Price
Shares after: 0
Date: 02 Oct 2025
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 2,490
Exercise price
Footnotes: F1, F3, F5, F7

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Section 16 status

Jeffrey J. Scherman is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may still apply in specific circumstances.

Explanation of responses 7 footnotes

Footnote F1

On October 2, 2025, NH Holdings 2025, Inc. ("Parent"), acquired the Issuer pursuant to a certain Agreement and Plan of Merger entered into by and among the Issuer, Parent and NH Holdings Acquisition 2025, Inc., a wholly-owned subsidiary of Parent ("Merger Sub"), dated as of December 23, 2024 (the "Merger Agreement"). In accordance with the Merger Agreement, the Issuer merged with and into Merger Sub, with the Issuer surviving such merger as a wholly-owned subsidiary of Parent (the "Merger"). Parent and Merger Sub are indirectly controlled by private investment funds affiliated with New Enterprise Associates, Inc.

Footnote F2

At the effective time of the Merger ("Effective Time"), each issued and outstanding share of the Issuer's common stock (other than certain excluded shares) automatically converted into the right to receive $7.33 in cash, without interest and less any applicable withholding taxes (the "Merger Consideration").

Footnote F3

Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.

Footnote F4

The original grant of these restricted stock units vest in equal annual installments beginning on 3/11/24.

Footnote F5

Each Issuer restricted stock unit ("RSU") outstanding immediately prior to the Effective Time was assumed and adjusted into a restricted stock unit with respect to a number of shares of common stock of Parent equal to the number of shares of Issuer common stock subject to such Issuer RSU and continued to be subject to the same terms and restrictions set forth in the Issuer equity plans and any applicable individual award agreement issued thereunder (including with respect to vesting).

Footnote F6

All of these restricted stock units vest on 10/11/26.

Footnote F7

The original grant of these restricted stock units vest in equal annual installments beginning on 3/6/23.